FREQUENCY OF SMOKING AND ITS RELATIONSHIP TO ISCHEMIC HEART DISEASE IN SAUDI MALE DIABETIC PATIENTS

Main Article Content

Syed Shahid Habib
Ashraf Husain
Kausar Naz
Laila Al Dokhi

Abstract

Objectives: 1) To find out the frequency of smoking in Saudi diabetic patients and to know the frequency of ischemic heart disease (IHD) in regular smoker, ex-smoker and non-smoker diabetic subjects. 2): To evaluate and compare the glycemic and lipid control between diabetic smokers and diabetic non-smokers. Methodology: This cross sectional study was conducted at department of Physiology and Medicine, College of Medicine, King Saud University. A total of 1000 Saudi diabetic patients (509 Males & 491 females) were studied. They were evaluated for the presence of IHD and cardiovascular risk factors. Smoking was defined as current regular cigarette smoking or ex-smoking without regard to daily consumption. Results: The frequency of regular smokers in males was 6.87% (n=35), ex-smokers was 6.09% (n=31) and overall it was found to be 12.97% (n=66). Only 2 females were found to be smokers (0.20%). Therefore, only male subjects were studied. The ex-smokers and all smokers had higher body mass index than non-smokers (p<0.05). Smokers had poor glycemic control compared to non-smokers (p<0.05). Triglyceride levels were higher in ex-smokers and all smokers compared to never smokers (p<0.05). Prevalence of IHD in non smokers was 13.77%. In regular smoker and ex-smokers frequency of IHD was 22.58 and 24.24% respectively. Odds ratio of IHD in smokers was 2 (p<0.05). Conclusions: The frequency of smoking in Saudi diabetic patients is 12.97%. Diabetic smokers have poor glycemic and lipid control than non-smokers. Smoking doubles the risk of IHD in diabetes mellitus. Frequency of IHD is similar between regular and ex-smokers. Key Words: Smoking, Diabetes Mellitus, Dyslipidemia, Ischemic Heart Disease This article may be cited as: Habib SS, Husain A, Naz K, Dokhi LA. Frequency of smoking and its relationship to ischemic heart disease in Saudi diabetic males. Khyber Med Univ J 2012; 4(4): 149-155.

Article Details

How to Cite
Habib, Syed Shahid, et al. “FREQUENCY OF SMOKING AND ITS RELATIONSHIP TO ISCHEMIC HEART DISEASE IN SAUDI MALE DIABETIC PATIENTS”. KHYBER MEDICAL UNIVERSITY JOURNAL, vol. 4, no. 4, Dec. 2012, pp. 149-55, https://www.kmuj.kmu.edu.pk/article/view/10990.
Section
Original Articles
Author Biography

Syed Shahid Habib, College of Medicine and King Khalid University Hospital, King Saud University, Riyadh, Saudi Arabia

Dept of Basic and Clinical Physiology

Associate Professor and Consultant Neurophysiology

References

Al-Khawlani A, Atef ZA, Al-Ansi A. Macrovascular complications and their associated risk factors in type 2 diabetic patients in Sana’a city, Yemen. East Mediterr Health J

;16(8):851-8.

Imperatore G, Cadwell BL, Geiss L, Saadinne JB, Williams

DE, Ford ES, et al. Thirty-year trends in cardiovascular

risk factor levels among US adults with diabetes:

National Health and Nutrition Examination Surveys,

-2000. Am J Epidemiol 2004;160(6):531-9.

Schipf S, Schmidt CO, Alte D, Werner A, Scheidt-Nave

C, John U, et al. Smoking prevalence in Type 2 diabetes:

results of the Study of Health in Pomerania (SHIP) and

the German National Health Interview and Examination

Survey (GNHIES). Diabet Med 2009;26(8):791-7.

Siddiqui S, Ogbeide DO, Al Khalifa I. Smoking in a Saudi

community: prevalence, influencing factors, and risk

perception. Fam Med 2001;33(5):367-70.

Siddiqui S, Ogbeide DO. Profile of smoking amongst

health staff in a primary care unit at a general hospital in

Riyadh, Saudi Arabia. Saudi Med J 2001;22(12):1101-4.

Haire-Joshu D, Glasgow RE, Tibbs TL Smoking and

diabetes. Diabetes Care 1999, 22:1887-98

National Cholesterol Education Program (NCEP) Expert

Panel on Detection, Evaluation, and Treatment of High

Blood Cholesterol in Adults (Adult Treatment Panel

III). Third Report of the National Cholesterol Education

Program (NCEP) Expert Panel on Detection, Evaluation,

and Treatment of High Blood Cholesterol in Adults

(Adult Treatment Panel III) final report. Circulation 2002;

:3143-421.

Solberg LI, Desai JR, O’Connor PJ, Bishop DB, Devlin

HM. Diabetic Patients Who Smoke: Are They Different?

Ann Fam Med 2004;2:26-32.

Sargeant LA, Khaw KT, Bingham S, Day NE, Luben RN,

Oakes S, et al. Cigarette smoking and Glycaemia, The

EPIC Norfolk study. Int J Epidemiol 2001;30:547-54

Thomas GN, Tomlinson B, McGhee SM, Lam TH,

Abdullah AS, Yeung VT, et al. Association of smoking

with increasing vascular involvement in type 2 diabetic

Chinese patients. Exp Clin Endocrinol Diabetes

;114(6):301-5.

Gulliford MC, Sedgwick JE, Pearce AJ. Cigarette smoking,

health status, socio-economic status and access to

health care in diabetes mellitus: a cross-sectional survey.

BMC Health Serv Res 2003;3(1):4.

Ruggiero L, Rossi JS, Prochaska JO, Glasgow RE, de

Groot M, Drfyfoos JM. Smoking and diabetes: readiness

for change and provider advice. Addictive Behaviors

, 24:573-8.

Stead LF, Lancaster T. Combined pharmacotherapy

and behavioral interventions for smoking cessation.

Cochrane Database Syst Rev 2012 Oct 17;10:CD008286.

McCulloch P, Lee S, Higgins R, McCall K, Schade DS.

Effect of smoking on hemoglobin A1c and body mass

index in patients with type 2 diabetes mellitus. J Investig

Med 2002;50(4):284-7.

PM, Gudbjornsdottir S, Eliasson B, Cederholm J. Smoking

is associated with increased HbA1c values and microalbuminuria in patients with diabetes--data from the

National Diabetes Register in Sweden. Diabetes Metab

;30(3):261-8.

Buchanan TA, Hodis HN, Li Y, Mack WJ. The association

of smoking and subclinical atherosclerosis in Type 2

diabetes: modification by duration of diabetes. Diabet

Med 2005;22(1):81-7.

Joshu DH, Russell E. Glasgow, Tiffany L. Tibbs, MA.

Smoking and Diabetes. Diabetes Care 1999;22:1887–98,

American Diabetes Association: Smoking and diabetes

(Position Statement). Diabetes Care 2004:27 (Suppl.

:S74–5

U.S. Preventive Services Task Force: Counseling to

prevent tobacco use. In Guide to Clinical Preventive

Services. 2nd ed. Baltimore, MD, Williams & Wilkins,

, p. 597–609

Fiore M, Bailey W, Cohen S. Smoking Cessation: Clinical

Practice Guideline Number 18. 1996. Department

of Health and Human Services, Public Health Service,

Agency for Health Care Policy and Research.

Thorndike AN, Regan S, Rigotti NA. The treatment of

smoking by US physicians during ambulatory visits:

-2003. Am J Public Health 2007;97(10):1878-83.

Goldstein MG, Niaura R, Willey-Lessne C, DePue J, Eaton

C, Rakowski W, et al. Physicians counseling smokers.

A population-based survey of patients’ perceptions of

health care provider-delivered smoking cessation interventions. Arch Intern Med 1997;157:1313-9.

Canga N, De Irala J, Vara E, Duaso MJ, Ferrer A, Martinez-

Gonzalez MA. Intervention study for smoking

cessation in diabetic patients: a randomized controlled

trial in both clinical and primary care settings. Diabetes

Care 2000;23(10):1455-60.

Chouinard MC, Robichaud-Ekstrand S. The effectiveness

of a nursing inpatient smoking cessation program

in individuals with cardiovascular disease. Nurs Res

;54(4):243-54.

Smith PM, Burgess E. Smoking cessation initiated during

hospital stay for patients with coronary artery disease:

a randomized controlled trial. Canadian Med Assoc J

; 180(13):1297-303.

Thorndike AN, Regan S, McKool K, Pasternak RC,

Swartz S, Torres-Finnerty N, et al. Depressive symptoms

and smoking cessation after hospitalization for cardiovascular

disease. Arch Intern Med 2008;168(2):186-91.

Rigotti NA, Arnsten JH, McKool KM, Wood-Reid KM, Pasternak RC, Singer DE. Efficacy of a smoking cessation

program for hospital patients. Arch Intern Med 1997;

: 2653–60.

Centers for Disease Control and Prevention. National

diabetes fact sheet: national estimates and general

information on diabetes and prediabetes in the United States, 2011. Atlanta, GA: U.S. Department of Health

and Human Services, Centers for Disease Control and

Prevention, 2011 URL: http://www.cdc.gov/diabetes/

pubs/factsheet11.htm